![]()
MIRA INFORM REPORT
|
Report Date : |
05.10.2011 |
IDENTIFICATION DETAILS
|
Name : |
PHARMA INTERNATIONAL CO (PIC) |
|
|
|
|
Registered Office : |
Abu Al Haj
Building, Al Jubaiha Area, P O Box 334, Amman 11941 |
|
|
|
|
Country : |
Jordan |
|
|
|
|
Date of Incorporation : |
02.01.1994 |
|
|
|
|
Com. Reg. No.: |
3400, Amman |
|
|
|
|
Legal Form : |
Limited Liability Company |
|
|
|
|
Line of Business : |
Manufacture and marketing of pharmaceuticals |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Maximum Credit Limit : |
US$ 300,000 |
|
|
|
|
Status : |
Satisfactory |
|
|
|
|
Payment
Behaviour : |
No Complaints |
|
|
|
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31st, 2011
|
Country Name |
Previous Rating (31.12.2010) |
Current Rating (31.03.2011) |
|
Jordan |
b1 |
b1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
Company Name : PHARMA INTERNATIONAL CO (PIC)
Also Known As : PHARMATEC INTERNATIONAL CO
Country of Origin : Jordan
Legal Form : Limited Liability Company
Registration Date : 2nd January 1994
Commercial Registration Number : 3400, Amman
Chamber Membership Number : 108000
National ID Number : 20009818
Issued Capital : JD 288,016,000
Paid up Capital : JD 288,016,000
Total Workforce : 770
Activities : Manufacture and marketing of pharmaceuticals.
Financial Condition : Undetermined
Payments : Nothing detrimental uncovered
Recommended Credit Limit : US$ 300,000
Person Interviewed : Thamer Haddad, Planning Manager
PHARMA INTERNATIONAL CO (PIC)
PHARMATEC INTERNATIONAL CO
Registered &
Physical Address
Building : Abu Al Haj Building
Area : Al Jubaiha Area
PO Box : 334
Town : Amman 11941
Country : Jordan
Telephone : (962-6) 5336502 / 5150581 / 5158890 /
5150580 / 5150580 / 5157893 / 5154296
Facsimile : (962-6) 5339163 / 5160865 / 5150583
/ 5154783
Email : ipcc@go.com.jo
/ riuad-abuhaj@pic-jo.com / marketing@pic-jo.com
Premises
Subject operates
from a medium sized suite of offices that are owned and located in the Suburban
Business Area of Amman.
Branch Office (s)
Location Description
·
Qastel
Area Owned
manufacturing plant
Amman
Tel: (962-6) 4711585 / 4711586
/ 4440585 / 4440586 / 4792222
Fax: (962-6) 4711803 / 4711584
Name Position
·
Ali
Mohamed Hussain Abu Al Haj Managing
Director
·
Riuad
Ali Mohamed Hussain Abu Al Haj Director
·
Osama
Ali Mohamed Hussain Abu Al Haj Director
·
Sahr
Ali Mohamed Hussain Abu Al Haj Director
·
Ahlam
Ali Mohamed Hussain Abu Al Haj Director
·
Gadeer
Ali Mohamed Hussain Abu Al Haj Director
·
Samar
Ali Mohamed Hussain Abu Al Haj Director
·
Raed
Omar Mohamed Hussain Abu Al Haj Director
·
Khalid
Mohamed Hussain Abu Al Haj Director
·
Paul
Glover General
Manager
·
Gamal Al Refai Production
Manager
·
Dr Nasser Al Hamawi Marketing
Manager
·
Thamer Haddad Planning
Manager
·
Alaa Hafez Commercial
Manager
·
Omar Al Hoor Factory
Manager
·
Yousef Al Zaghari Finance
Manager
Date of Establishment : 2nd
January 1994
Legal Form :
Limited Liability Company
Commercial Reg. No. : 3400, Amman
Chamber Member No. : 108000
National ID No. : 20009818
Issued Capital : JD 288,016,000
Paid up Capital : JD 288,016,000
Name of
Shareholder (s)
·
Ali
Mohamed Hussain Abu Al Haj
·
Riuad
Ali Mohamed Hussain Abu Al Haj
·
Osama
Ali Mohamed Hussain Abu Al Haj
·
Sahr
Ali Mohamed Hussain Abu Al Haj
·
Ahlam
Ali Mohamed Hussain Abu Al Haj
·
Gadeer
Ali Mohamed Hussain Abu Al Haj
·
Samar
Ali Mohamed Hussain Abu Al Haj
·
Raed
Omar Mohamed Hussain Abu Al Haj
·
Khalid
Mohamed Hussain Abu Al Haj
Activities: Manufacture and marketing of
pharmaceuticals, including antibiotics, cephalosporin and noncephalosporin, antifungals,
cardiovascular, nervous system, iron preparations and dermatological
preparations under license from Schein Pharmaceuticals of the USA.
Subject is ISO 9001 accredited.
Import
Countries: The United
States of America, Switzerland, France and Germany.
Export
Countries: Iran, the Middle
East, Africa and Russia.
Subject has a
workforce of approximately 770 employees.
Companies
registered in Jordan are not legally required to make their accounts public and
no financial information was released by the company or submitted by outside
sources.
·
Arab
Bank Plc
Shmeisani Branch
PO Box: 950545 & 950544
Amman 11195
Tel: (962-6) 5607231 / 5607115
Fax: (962-6) 5606793 / 5606830
·
HSBC
Bank Middle East
Khalid Bin Walid Street
Jebel Hussein
PO Box: 925286
Amman
Tel: (962-6) 5660471 / 5607471
Fax: (962-6) 5692964
No complaints
regarding subject’s payments have been reported.
Credit amount 150,000
Amount overdue 0
Payment terms 60
days
Payment Method Letters
of Credit
Paying record No
Complaints
Currency US
Dollars
Pharma
International Co (PIC) is engaged in the manufacture and marketing of
pharmaceuticals. It has recently signed a licensing agreement with Schein Pharmaceuticals of the
USA.
Local
sources report that subject is making good progress in the regional
pharmaceutical industry and is under the direction of a professional management
team.
During the course
of this investigation nothing detrimental was uncovered regarding subject’s operating
history or the manner in which payments are fulfilled. As such the company is
considered to be a fair trade risk.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.49.23 |
|
UK Pound |
1 |
Rs.76.07 |
|
Euro |
1 |
Rs.65.06 |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
---- |
NB |
New Business |
---- |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.